Status:
UNKNOWN
Influence of Therapeutic Education in Patients With Joint Inflammation Treated With a Biological Treatment
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Non-radiographic Spondyloarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To describe, with a patient reported score (BIOSECURE), the influence of an approved therapeutic education program (TEP) in patients with joint inflammation requiring a biological treatment initiation...
Eligibility Criteria
Inclusion
- Non-radiological spondyloarthritis diagnosis (ASAS criteria)
- Anti-TNFalpha biological treatment initiation required
- Adult patient (age\>18years)
- Capacity to understand self-questionnaires and address questions
- Patient accepting to attend a therapeutic education program (TEP)
Exclusion
- Previous Anti-TNFalpha biological treatment
- Previous attendance to a TEP concerning biological or spondyloarthritis
- Contraindication to Anti-TNFalpha treatment
- Associated and unbalanced diseases
Key Trial Info
Start Date :
January 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 16 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03360864
Start Date
January 16 2020
End Date
January 16 2023
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67000